Rchr
J-GLOBAL ID：200901011774422412
Update date: Sep. 23, 2024
Matsunaga Toshiyuki
マツナガ トシユキ | Matsunaga Toshiyuki
Affiliation and department：
Job title：
Professor
Research field (3)：
Pathobiochemistry
, Tumor biology
, Pharmaceuticals - health and biochemistry
Research keywords (5)：
illegal drugs
, chemoresistance
, reactive oxygen species
, aldo-keto reductase
, 酸化リポタンパク
Research theme for competitive and other funds (2)：
- 2015 - 2019 Oxidative stress-related factor as a novel target for drug-resistant prostate cancer
- 2011 - 2012 Relationship between high-density lipoprotein particles and dyslipidemia risk
Papers (222)：
-
Yuko Mizukami, Ayaka Ito, Shotaro Hashimoto, Tomoka Ando, Yoshinobu Ishikawa, Hiroaki Eguchi, Yuta Yoshino, Toshiyuki Matsunaga, Akira Ikari. Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells. Archives of biochemistry and biophysics. 2024. 758. 110075-110075
-
Riho Kimura, Shotaro Hashimoto, Hiroaki Eguchi, Yoshifumi Morikawa, Koichi Suenami, Yuta Yoshino, Toshiyuki Matsunaga, Satoshi Endo, Akira Ikari. Enhancement of chemoresistance by claudin-1-mediated formation of amino acid barriers in human lung adenocarcinoma A549 cells. Archives of biochemistry and biophysics. 2024. 759. 110106-110106
-
Satoshi Endo, Yoshifumi Morikawa, Koichi Suenami, Yuji Sakai, Naohito Abe, Toshiyuki Matsunaga, Akira Hara, Masaki Takasu. Involvement of porcine and human carbonyl reductases in the metabolism of epiandrosterone, 11-oxygenated steroids, neurosteroids, and corticosteroids. The Journal of steroid biochemistry and molecular biology. 2024. 106574-106574
-
Hiroaki Eguchi, Yaqing Yu, Toshiyuki Matsunaga, Yuta Yoshino, Akira Ikari. Acrolein suppresses anticancer drug-induced toxicity mediated by activating claudin-1 and Nrf2 axis in a spheroid model of human lung squamous cell carcinoma cells. Toxicology letters. 2024. 392. 46-55
-
Yuri Nagaoka, Kotone Oshiro, Yuta Yoshino, Toshiyuki Matsunaga, Satoshi Endo, Akira Ikari. Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells. Archives of biochemistry and biophysics. 2024. 751. 109824-109824
ｍore...
MISC (31)：
-
太田篤実, 河合弥菜, 工藤優大, 河野真也, 市原賢二, 松永俊之, 五十里彰, 遠藤智史. The search for naturally derived ingredients to improve the treatments of prostate cancer. 日本薬学会年会要旨集(Web). 2021. 141st
-
工藤優大, 松永俊之, 遠藤智史. Identification of reductive metabolic enzymes of 11-keto-C19-steroids. 日本薬学会年会要旨集(Web). 2020. 140th
-
奈迫遥華, 秋月梨佐, 高階優衣, 石川吉伸, 篠田雄大, 遠藤智史, 松永俊之, 五十里彰. Increase in anticancer drug-induced toxicity targeting the cell adhesion molecule claudin-2. 日本薬学会年会要旨集(CD-ROM). 2020. 140th
-
Tsugikazu Komoda, Toshiyuki Matsunaga. Biochemistry for Medical Professionals. Biochemistry for Medical Professionals. 2015. 1-101
-
Toshiyuki Matsunaga, Akira Hara, Tsugikazu Komoda. Functional change in the HDL particle by oxidative modification and its contribution to atherogenesis. The HDL Handbook. 2010. 215-241
ｍore...
Patents (2)：
Professional career (2)：
- Master(Pharmaceutics) (Gifu Pharmaceutical University)
- Doctor(Pharmaceutics) (Gifu Pharmaceutical University)
Work history (1)：
- 2019/04 - 現在 Gifu Pharmaceutical University Education Center of Green Pharmaceutical Sciences Professor
Return to Previous Page
